For the third consecutive year, the Alliance convened a panel at the 2026 J.P. Morgan Healthcare Conference (JPM) in San Francisco, followed by an Alliance side meeting held at Accenture’s San Francisco Innovation Hub. This year’s panel brought together leaders from Gilead Sciences, U.S. Development Finance Corporation (DFC), Nivi, Inc., reach52, and Accenture to explore how pharmaceutical partnerships, development finance, and patient platforms are creating investable infrastructure in high-growth markets across Asia and Africa. The panel underscored that the most promising long-term opportunities in emerging markets lie not just in individual products, but in the systems and partnerships that connect them to patients.
